Brown, Lisle/Cummings, Inc. Becton Dickinson & CO Transaction History
Brown, Lisle/Cummings, Inc.
- $390 Billion
- Q3 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 833 shares of BDX stock, worth $148,865. This represents 0.04% of its overall portfolio holdings.
Number of Shares
833
Previous 917
9.16%
Holding current value
$148,865
Previous $158 Million
1.29%
% of portfolio
0.04%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding BDX
# of Institutions
1,754Shares Held
260MCall Options Held
1.82MPut Options Held
696K-
Vanguard Group Inc Valley Forge, PA32.3MShares$5.77 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$3.98 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$2.89 Billion1.76% of portfolio
-
State Street Corp Boston, MA13.4MShares$2.4 Billion0.09% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.15MShares$1.64 Billion0.57% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $51B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...